Skip to main content
SpringerLink
Log in
Book cover

Cutaneous Lupus Erythematosus pp 117–132Cite as

Drug-Induced Lupus Erythematosus

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams LE, Hess EV (1991) Drug-related lupus. Drug Safety 6:431–449

    PubMed  Google Scholar 

  • Alarcon-Segovia D, Fishbein E, Reyes PA, Dies H, Shwadsky S (1972) Antinuclear antibodies in patients on anticonvulsant therapy. Clin Exp Immunol 12:39–47

    PubMed  Google Scholar 

  • Alloway JA, Salata MP (1995) Quinidine-induced rheumatic syndromes. Semin Arthritis Rheum 24:315–322

    Article  PubMed  Google Scholar 

  • Amrhein JA, Kenny FM, Ross D (1970) Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J Pediatr 76:54–63

    PubMed  Google Scholar 

  • Aucoin DP, Peterson ME, Hurvitz AI, Drayer DE, Lahita RG, Quimby FW, Reidenberg MM (1985) Propylthiouracil-induced immune-mediated disease in the cat. J Pharmacol Exp Ther 234:13–18

    PubMed  Google Scholar 

  • Aucoin DP, Rubin RL, Peterson ME, Reidenberg MM, Drayer DE, Hurvitz AI, Lahita RG (1988) Dose-dependent induction of anti-native DNA antibodies in cats by propylthiouracil. Arthritis Rheum 31:688–692

    PubMed  Google Scholar 

  • Batchelor JR, Welsh KI, Tinoco RM, Dollery CT, Hughes GR, Bernstein R, Ryan P, Naish PF, Aber GM, Bing RF, Russel GI (1980) Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet 1:1107–1109

    Article  PubMed  Google Scholar 

  • Beernink DH, Miller JJ (1973) Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children. J Pediatr 82:113–117

    PubMed  Google Scholar 

  • Blomgren SE, Condemi JJ, Vaughn JH (1972) Procainamide-induced lupus erythematosus: clinical and laboratory observations. Am J Med 52:338–348

    Article  PubMed  Google Scholar 

  • Booth RJ, Wilson JD, Bullock JY (1982) β-Adrenergic-receptor blockers and antinuclear antibodies in hypertension. Clin Pharmacol Ther 31:555–558

    PubMed  Google Scholar 

  • Brand C, Davidson A, Littlejohn G, Ryan P (1984) Hydralazine-induced lupus: no association with HLA-DR4. Lancet 1:462

    Article  Google Scholar 

  • Burlingame RW, Rubin RL (1991) Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest 88:680–690

    PubMed  Google Scholar 

  • Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose therapy. Br Med J 289:410–412

    Google Scholar 

  • Canoso R, Lewis M, Yunis E (1982) Association of HLA-Bw44 with chlorpromazine-induced autoantibodies. Clin Immunol Immunopathol 25:278–282

    PubMed  Google Scholar 

  • CAST (1989) Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406–412

    Google Scholar 

  • Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN (2000) Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, A monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 43:2383–2390

    Article  PubMed  Google Scholar 

  • Chin G, Kong N, Lee B, Rose I (1991) Penicillamine induced lupus-like syndrome in a patient with classical rheumatoid arthritis. J Rheumatol 18:947–948

    PubMed  Google Scholar 

  • Christie DJ, Mullen PC, Aster RH (1985) Fab-mediated binding of drug-dependent antibodies to platelets in quinidine-and quinine-induced thrombocytopenia. J Clin Invest 75:310–314

    PubMed  Google Scholar 

  • Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B (1988) Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 140:2197–2200

    PubMed  Google Scholar 

  • Derksen R, Kater L (1985) Lupus anticoagulant: revival of an old phenomenon. Clin Exp Rheumatol 3:349–357

    PubMed  Google Scholar 

  • Donker AJ, Venuto RC, Vladutiu AO, Brentjens JR, Andres GA (1984) Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Clin Immunol Immunopath 30:142–155

    Article  Google Scholar 

  • Dubois EL, Wallace DJ (1987) Drugs that exacerbate and induce systemic lupus erythematosus In: Wallace DJ, Dubois EL (eds) Dubois’ Lupus Erythematosus. Lea & Febiger, Philadelphia, pp 450–469

    Google Scholar 

  • Dubois EL, Tallman E, Wonka RA (1972) Chlorpromazine-induced systemic lupus erythematosus: case report and review of the literature. J Am Med Assoc 221:595–596

    Article  Google Scholar 

  • Dubroff LM, Reid R Jr, Papalian M (1981) Molecular models for hydralazine-related systemic lupus erythematosus. Arthritis Rheum 24:1082–1085

    PubMed  Google Scholar 

  • Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ (2000) Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 142:461–467

    Article  PubMed  Google Scholar 

  • Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115–4119

    PubMed  Google Scholar 

  • Fritzler MJ, Tan EM (1978) Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest 62:560–567

    PubMed  Google Scholar 

  • Fukuyama S, Kajiwara E, Suzuki N, Miyazaki N, Sadoshima S, Onoyama K (2000) Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature. Am J Gastroenterol 95:310–312

    PubMed  Google Scholar 

  • Ghate J, Turner M, Rudek M, Figg W, Dahut W, Dyer V, Pluda J, Reed E (2001) Drug-induced lupus associated with COL-3: report of 3 cases. Arch Dermatol 137:471–474

    PubMed  Google Scholar 

  • Gleichmann E, Pals WT, Rolink AG, Radaszkiewicz T, Gleichmann H (1984) Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 5:324–332

    Article  Google Scholar 

  • Gleichmann H (1982) Systemic lupus erythematosus triggered by diphenylhydantoin. Arthritis Rheum 25:1387–1388

    Google Scholar 

  • Graninger WB, Hassfeld W, Pesau BB, Machold KP, Zielinski CC, Smolen JS (1991) Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Rheumatol 18:1621–1622

    PubMed  Google Scholar 

  • Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133–141

    Article  PubMed  Google Scholar 

  • Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B (1997) Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br J Rheumatol 36:1089–1094

    PubMed  Google Scholar 

  • Hahn BH, Sharp GC, Irvin WS, Kantor OS, Gardner CA, Bagby MK, Perry HM Jr, Osterland CK (1972) Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus. Ann Intern Med 76:365–374

    PubMed  Google Scholar 

  • Harkcom TM, Conn DL, Holley KE (1978) D-Penicillamine and lupus erythematosus-like syndrome. Ann Intern Med 89:1012

    Google Scholar 

  • Henningsen NC, Cederberg A, Hanson A, Johansson BW (1975) Effects of long-term treatment with procaine amide. Acta Med Scand 198:475–482

    PubMed  Google Scholar 

  • Hieronymus T, Grotsch P, Blank N, Grunke M, Capraru D, Geiler T, Winkler S, Kalden JR, Lorenz HM (2000) Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus? Arthritis Rheum 43:1994–2004

    PubMed  Google Scholar 

  • Hoffman BJ (1945) Sensitivity to sulfadiazine resembling acute lupus erythematosus. Arch Dermatol Syph 51:190–192

    Google Scholar 

  • Hofstra A, Uetrecht JP (1993) Metabolism of hydralazine to a reactive intermediate by the oxidizing system of activated leukocytes. Chem Biol Interact 89:183–196

    Article  PubMed  Google Scholar 

  • Jaffe IA (1981) Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases. Springer Semin Immunopathol 4:193–207

    Article  PubMed  Google Scholar 

  • Jain KK (1991) Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy. Drug Saf 6:350–360

    PubMed  Google Scholar 

  • Ju C, Uetrecht JP (1999) Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther 288:51–56

    PubMed  Google Scholar 

  • Kalyanaraman B, Sohnle PG (1985) Generation of free radical intermediates from foreign compounds by neutrophil-derived oxidants. J Clin Invest 75:1618–1622

    PubMed  Google Scholar 

  • Kammuller ME, Bloksma N, Seinen W (1988) Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds. J Toxicol Clin Toxicol 26:157–174

    PubMed  Google Scholar 

  • Khan MF, Kaphalia BS, Prabhakar BS, Kanz MF, Ansari GA (1995) Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 134:155–160

    Article  PubMed  Google Scholar 

  • Kilburn KH, Warshaw RH (1992) Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res 57:1–9

    Article  PubMed  Google Scholar 

  • Knezevic W, Mastaglia FL, Quintner J, Zilko PJ (1984) Guillain-Barré syndrome and pemphigus foliaceus associated with D-penicillamine therapy. Aust NZ J Med 14:50–52

    Google Scholar 

  • Kretz-Rommel A, Duncan SR, Rubin RL (1997) Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus. J Clin Invest 99:1888–1896

    PubMed  Google Scholar 

  • Kretz-Rommel A, Rubin RL (1999) Persistence of autoreactive T cell drive is required to elicit antichromatin antibodies in a murine model of drug-induced lupus. J Immunol 162:813–820

    PubMed  Google Scholar 

  • Laversuch CJ, Collins DA, Charles PJ, Bourke BE (1995) Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol 34:435–439

    PubMed  Google Scholar 

  • Lawson TM, Amos N, Bulgen D, Williams BD (2001) Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) 40:329–335

    Article  PubMed  Google Scholar 

  • Lee SL, Chase PH (1975) Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum 5:83–103

    Article  PubMed  Google Scholar 

  • Lessard E, Fortin A, Belanger PM, Beaune P, Hamelin BA, Turgeon J (1997) Role of CYP2D6 in the N-hydroxylation of procainamide. Pharmacogenetics 7:381–390

    PubMed  Google Scholar 

  • Machold KP, Smolen JS (1990) Interferon-gamma induced exacerbation of systemic lupus erythematosus. J Rheumatol 17:831–832

    PubMed  Google Scholar 

  • Mackie BS, Mackie LE (1999) The PABA story. Australas J Dermatol 40:51–53

    Article  PubMed  Google Scholar 

  • Maddrey WC, Boitnott JK (1973) Isoniazid hepatitis. Ann Intern Med 79:1–12

    PubMed  Google Scholar 

  • Malinow MR, Bardana EJ, Pirofsky B, Craig S, McLaughlin P (1982) Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 216:415–417

    PubMed  Google Scholar 

  • Markham A, Lamb HM (2000) Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs 59:1341–1359

    PubMed  Google Scholar 

  • Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S (1992)Minocycline-related lupus. Lancet 340:1553

    Article  PubMed  Google Scholar 

  • Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A (1990) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 81:380–383

    PubMed  Google Scholar 

  • Perry HM (1973) Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. Am J Med 54:58–72

    Article  PubMed  Google Scholar 

  • Perry HM, Tan EM, Cordody S, Sahamato A (1970) Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms on hypertensive patients treated with hydralazine. J Lab Clin Med 76:114–125

    PubMed  Google Scholar 

  • Portanova JP, Arndt RE, Tan EM, Kotzin BL (1987) Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions. J Immunol 138:446–451

    PubMed  Google Scholar 

  • Price EJ, Venables PJ (1995) Drug-induced lupus. Drug Saf 12:283–290

    PubMed  Google Scholar 

  • Raftery EB, Denman AM (1973) Systemic lupus erythematosus syndrome induced by practolol. Br Med J 2:452–455

    PubMed  Google Scholar 

  • Reidenberg MM (1983) Aromatic amines and the pathogenesis of lupus erythematosus. Am J Med 75:1037–1042

    Article  PubMed  Google Scholar 

  • Reidenberg MM, Durant PJ, Harris RA, De Boccardo G, Lahita R, Stenzel KH (1983) Lupus erythematosus-like disease due to hydrazine. Am J Med 75:365–370

    Article  PubMed  Google Scholar 

  • Reza MJ, Dornfeld L, Goldberg LS (1975) Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus. Arthritis Rheum 18:335–338

    PubMed  Google Scholar 

  • Rich MW (1996) Drug-induced lupus: the list of culprits grows. Postgrad Med 100:299–308

    PubMed  Google Scholar 

  • Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M (1990) Evidence for impaired T cell methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33:1665–1673

    PubMed  Google Scholar 

  • Ronnblom LE, Alm GV, Oberg KE (1990) Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 227:207–210

    PubMed  Google Scholar 

  • Rothfield NF, Bierer WF, Garfield JW (1978) Isoniazid induction of antinuclear antibodies: a prospective study. Ann Intern Med 88:650–652

    PubMed  Google Scholar 

  • Rutgeerts P, D’Haens G, Targan S, Vasiliaskas E, Hanauer SB, Present DH, Mayer L, Van Hogezand RA, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJ (1999) Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology 117:761–769

    PubMed  Google Scholar 

  • Schaffer JV, Davidson DM, McNiff JM, Bolognia JL (2001) Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 44:198–206

    Article  PubMed  Google Scholar 

  • Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68:1536–1537

    PubMed  Google Scholar 

  • Shapiro KS, Pinn VW, Harrington JT, Levey AS (1984) Immune complex glomerulnephritis in hydralazine-induced SLE. Am J Kidney Dis 3:270–274

    PubMed  Google Scholar 

  • Shapiro LE, Knowles SR, Shear NH (1997) Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 133:1224–1230

    PubMed  Google Scholar 

  • Shapiro LE, Uetrecht J, Shear NH (2001) Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis. J Am Acad Dermatol 45:787–789

    PubMed  Google Scholar 

  • Shear NH, Spielberg SP (1988) Anticonvulsant hypersensitivity syndrome. J Clin Invest 82:1826–1832

    PubMed  Google Scholar 

  • Sim E, Law SA (1985) Hydralazine binds covalently to complement component C4: different reactivity of C4A and C4B gene products. FEBS 184:323–327

    Google Scholar 

  • Sim E, Stanley L, Gill EW, Jones A (1988) Metabolites of procainamide and practolol inhibit complement components C3 and C4. Biochem J 251:323–326

    PubMed  Google Scholar 

  • Spielberg SP, Gordon GB, Blake DA, Mellits ED, Bross DS (1981) Anticonvulsant toxicity in vitro: possible role of arene oxides. J Pharmacol Exp Ther 217:386–389

    PubMed  Google Scholar 

  • Stec GP, Lertora JJL, Atkinson AJ, Nevin MJ, Kushner W, Jones C, Schmid FR, Askenazi J (1979) Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapy. Ann Intern Med 90:799–801

    PubMed  Google Scholar 

  • Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM (1991) NIH conference. Systemic lupus erythematosus. Ann Intern Med 115:548–559

    PubMed  Google Scholar 

  • Tournade H, Pelletier L, Pasquier R, Vial M, Mandet C, Druet P (1990) D-Penicillamine-induced autoimmunity in Brown-Norway rats: similarities with HgCl2-Induced autoimmunity. J Immunol 144:2985–2991

    PubMed  Google Scholar 

  • Uetrecht JP (1988) Mechanism of drug-induced lupus. Chem Res Toxicol 1:133–143

    PubMed  Google Scholar 

  • Uetrecht JP (1996) Drug-induced lupus: possible mechanisms and their implications for prediction of which new drugs may induce lupus. Expert Opinion on Invest Drugs 5:851–860

    Google Scholar 

  • Uetrecht JP, Woosley RL (1981) Acetylator phenotype and lupus erythematosus. Clin Pharmacokin 6:118–134

    Google Scholar 

  • Waldhauser L, Uetrecht J (1991) Oxidation of propylthiouracil to reactive metabolites by activated neutrophils: implications for agranulocytosis. Drug Metab Dispos 19:354–359

    PubMed  Google Scholar 

  • Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317

    Article  PubMed  Google Scholar 

  • Wilson JD, Bullock JY, Sutherland DC, Main C, O’Brien KP (1978) Antinuclear antibodies in patients receiving non-practolol beta-blockers. Br Med J 1:14–16

    PubMed  Google Scholar 

  • Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA (1978) Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 298:1157–1159

    PubMed  Google Scholar 

  • Yung RL, Richardson BC (1994) Drug-induced lupus. Rheum Dis Clin North Am 20:61–86

    PubMed  Google Scholar 

  • Zarrabi MH, Zucker S, Miller F, Derman RM, Romano GS, Hartnett JA, Varma AO (1979) Imunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med 91:194–199.

    PubMed  Google Scholar 

Download references

Authors
  1. Jack Uetrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hautklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Annegret Kuhn  & Thomas Ruzicka  & 

  2. HELIOS Klinikum Wuppertal Klinik für Dermatologie, Allergologie und Umweltmedizin, Universitätsklinikum Witten-Herdecke, Arrenbergerstraße 20, 42117, Wuppertal, Germany

    Percy Lehmann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Uetrecht, J. (2005). Drug-Induced Lupus Erythematosus. In: Kuhn, A., Lehmann, P., Ruzicka, T. (eds) Cutaneous Lupus Erythematosus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26581-3_9

Download citation

  • DOI: https://doi.org/10.1007/3-540-26581-3_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-44266-0

  • Online ISBN: 978-3-540-26581-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation